Aziz Sawaf
2023
In 2023, Aziz Sawaf earned a total compensation of $1.4M as Senior Vice President, Chief Financial Officer at Theravance Biopharma.
Compensation breakdown
| Bonus | $9,000 |
|---|---|
| Non-Equity Incentive Plan | $126,000 |
| Salary | $448,500 |
| Stock Awards | $803,200 |
| Total | $1,386,700 |
Sawaf received $803.2K in stock awards, accounting for 58% of the total pay in 2023.
Sawaf also received $9K in bonus, $126K in non-equity incentive plan and $448.5K in salary.
Rankings
In 2023, Aziz Sawaf's compensation ranked 779th out of 2,225 executives tracked by ExecPay. In other words, Sawaf earned more than 65.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 779 out of 2,225 | 65th |
Division Manufacturing | 449 out of 1,207 | 63rd |
Major group Chemicals And Allied Products | 306 out of 677 | 55th |
Industry group Drugs | 298 out of 648 | 54th |
Industry Pharmaceutical Preparations | 203 out of 464 | 56th |
Source: SEC filing on April 5, 2024.
Sawaf's colleagues
We found two more compensation records of executives who worked with Aziz Sawaf at Theravance Biopharma in 2023.